Elekta (OTCMKTS:EKTAY) Sets New 52-Week High – What’s Next?

Shares of Elekta AB (OTCMKTS:EKTAY) hit a new 52-week high during trading on Thursday . The company traded as high as $6.32 and last traded at $6.32, with a volume of 435 shares trading hands. The stock had previously closed at $6.2750.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 16th. Three analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce”.

Elekta Price Performance

The company has a market cap of $2.38 billion, a P/E ratio of 92.16 and a beta of 1.04. The company’s 50-day moving average price is $5.54 and its two-hundred day moving average price is $5.21. The company has a current ratio of 1.04, a quick ratio of 0.79 and a debt-to-equity ratio of 0.66.

Elekta (OTCMKTS:EKTAY) last issued its quarterly earnings results on Wednesday, November 26th. The company reported $0.07 EPS for the quarter. Elekta had a net margin of 1.62% and a return on equity of 12.14%. The business had revenue of $427.85 million for the quarter, compared to analysts’ expectations of $436.91 million. As a group, sell-side analysts expect that Elekta AB will post 0.36 earnings per share for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.